Benchmark analyst Bill Sutherland downgraded Select Medical (SEM) to Hold from Buy with no price target after the company agreed to be acquired by a consortium led by Executive Chairman Bob Ortenzio for $16.50 per share in cash. Given an uneven five-year performance record, the firm expects a majority of shareholders will approve the deal despite a valuation at the lower end of its peer group, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEM:
- Select Medical downgraded to Hold from Buy at Deutsche Bank
- MongoDB downgraded, Block upgraded: Wall Street’s top analyst calls
- Select Medical agrees to go-private buyout transaction
- Select Medical downgraded to Sector Perform from Outperform at RBC Capital
- Select Medical to be acquired by consortium for $16.50 per share in cash